Abstract
The parenteral administration of protein hydrolysate-glucose mixtures is being used increasingly to prevent tissue catabolism and promote growth in infants with various conditions which preclude adequate ingestion or absorption of calories. Although nitrogen retention can be regularly attained, several complications have been reported.
We have found elevated blood ammonia levels in 5 of 6 infants receiving parenteral nutrition. In 4 of these infants, blood ammonia was >200μ g%. All 3 low-birth weight infants in the series developed hyperammonemia. Elevations of blood ammonia were seen during the infusion of either casein or fibrin hydrolysates. In 2 infants receiving long term infusions the level of blood ammonia correlated directly with the rate of infusion of protein hydrolysate whereas blood urea nitrogen levels did not change significantly. Elevation of serum transaminases and bilirubin accompanied hyperammonemia in 3 patients.
These data show that hyperammonemia is a common biochemical abnormality in newborn infants receiving parenteral nutrition with casein or fibrin hydrolysates at commonly employed infusion rates. Liver cell damage may accompany this mode of nutrition. The cause of hyperammonemia is unknown, but may be the result of an amino acid imbalance in the infusate.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johnson, J., Albritton, W. & Sunshine, P. Hyperammonemia complicating parenteral nutrition in infants. Pediatr Res 5, 414 (1971). https://doi.org/10.1203/00006450-197108000-00178
Issue date:
DOI: https://doi.org/10.1203/00006450-197108000-00178
